December 12, 2022 08:00 AM ESTUpdated 09:23 AM
Deals

Clo­vis files for bank­rupt­cy, will keep op­er­at­ing and plans to sell pipeline as­set to No­var­tis

Katherine Lewin

News Reporter

A lit­tle over a month since Clo­vis On­col­o­gy fired 115 em­ploy­ees and laid out its dire fi­nan­cial sit­u­a­tion, the bio­phar­ma com­pa­ny filed for Chap­ter 11 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

A service from the Financial Times